Key result
Medical management of periprocedural hypertension in vascular surgery involves continuing preoperative medications, avoiding cancellation unless BP exceeds 180/110 mm Hg, and avoiding oral nifedipine.
Provides guidance on managing periprocedural hypertension in vascular surgery, recommending procedure cancellation only for BP >180/110 mm Hg and avoiding oral nifedipine.
Answers are grounded in this paper and cite their sources.
May inform periprocedural BP thresholds in vascular surgery; leaves open prospective validation before changing practice.
Periprocedural hypertension is a common finding in patients undergoing vascular surgery or endovascular procedures, and this may pose a risk for subsequent cardiovascular morbidity or mortality. Accordingly, the vascular surgeon who wishes to improve outcomes needs to be proficient not only in surgical technique but also in the medical management of the patient's associated conditions, especially hypertension. Vascular procedures need not be cancelled unless the blood pressure (BP) is more than 180 mm Hg systolic or 110 mm Hg diastolic, but attention should also be paid to evidence of end organ damage in making this decision. In most cases preoperative antihypertensive medications should be continued up till the procedure. Postoperative hypertension may require 1 of a number of intravenous medications, which are listed. Oral nifedipine should generally be avoided for fear of inducing an uncontrolled hypotensive response and cardiac ischemia.
No takes yet. Share an insight, caveat, or question.
Russell H. Samson (2004) conducted a review in Periprocedural hypertension. Medical management of periprocedural hypertension was evaluated. Medical management of periprocedural hypertension in vascular surgery involves continuing preoperative medications, avoiding cancellation unless BP exceeds 180/110 mm Hg, and avoiding oral nifedipine.
Synapse has enriched 10 related papers. Consider them for comparative context: